<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02523066</url>
  </required_header>
  <id_info>
    <org_study_id>Magna Ease CN001</org_study_id>
    <nct_id>NCT02523066</nct_id>
  </id_info>
  <brief_title>Clinical Study to Evaluate the Performance of Magna Ease Heart Valve in Chinese Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Edwards (Shanghai) Lifesciences Medical Supplies Co.,Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Edwards (Shanghai) Lifesciences Medical Supplies Co.,Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical Study to Evaluate the Performance of Magna Ease Heart Valve in Chinese patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Echocardiography to evaluate the performance of heart valve</measure>
    <time_frame>Up to five years after surgery</time_frame>
    <description>Subjects are required to do eight times echocardiography in follow up visits</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Mitral Valve or Aortic Valve Replacement</condition>
  <arm_group>
    <arm_group_label>Mitral Valve or Aortic Valve Replancement</arm_group_label>
    <description>One-arm group</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Magna Ease</intervention_name>
    <description>This study is non-intervention</description>
    <arm_group_label>Mitral Valve or Aortic Valve Replancement</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The patients who had the heart valves (Type: 7300TFX and 3300TFX), and are willing to
        participate in the study.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patients who implanted with Magna Ease Heart Valve (Type:7300TFX and 3300TFX) in
             Fuwai Hospital in China.

          -  The patients agree to sign the inform consent form (ICF).

        Exclusion Criteria:

          -  No specific exclusion criteria.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Amber Fang, Master</last_name>
    <phone>0086-2153891888</phone>
    <phone_ext>1835</phone_ext>
    <email>Amber_fang@edwards.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Chinese academy of medical sciences fuwai hospital cardiovascular disease</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amber Fang, Master</last_name>
      <phone>0086-2153891888</phone>
      <phone_ext>1835</phone_ext>
      <email>Amber_fang@edwards.cn</email>
    </contact>
    <investigator>
      <last_name>Wei Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 6, 2015</study_first_submitted>
  <study_first_submitted_qc>August 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 14, 2015</study_first_posted>
  <last_update_submitted>August 13, 2015</last_update_submitted>
  <last_update_submitted_qc>August 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

